** Shares of telehealth firm Doximity DOCS.N slump 14.7% to $49.84 after co's forecast misses expectations
** Co forecasts FY26 revenue between $619 mln and $631 mln vs analysts' estimate of $635 mln - data compiled by LSEG
** Midpoint of Q1 revenue outlook also below estimate
** At least four brokerages cut PT, including Truist Securities
** Piper Sandler lowers PT but says they "would buy this morning's weakness" as co's top-line growth forecast is appropriate due to uncertain impact of policy
** Eight out of 20 analysts rate stock as "buy" or higher, 12 "hold"; median PT is $70
** Including session's moves, DOCS down 5.6% YTD
(Reporting by Twesha Dikshit)
((Twesha.Dikshit@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。